+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
Mid-Size Pharmaceuticals Market Report 2025 - Product Thumbnail Image

Mid-Size Pharmaceuticals Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
14-alpha Demethylase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

14-alpha Demethylase Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
H Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

H Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
Pompe Disease Treatment Market 2025-2033 - Product Thumbnail Image

Pompe Disease Treatment Market 2025-2033

  • Report
  • March 2025
  • 138 Pages
  • Global
From
From
Biopreservation Market Report 2023-2033 - Product Thumbnail Image

Biopreservation Market Report 2023-2033

  • Report
  • February 2023
  • 276 Pages
  • Global
From
Varicella Zoster (HHV-3) Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Varicella Zoster (HHV-3) Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Retinal Disorder Treatment Market Report 2025 - Product Thumbnail Image

Retinal Disorder Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator